Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of MOGAT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 8340.71 | 226 / 226 | 64% | 16.03 | 261 / 406 |
prostate | 91% | 218.70 | 224 / 245 | 71% | 3.73 | 356 / 502 |
intestine | 68% | 2983.00 | 656 / 966 | 73% | 13.07 | 383 / 527 |
stomach | 50% | 66.61 | 181 / 359 | 69% | 12.26 | 198 / 286 |
breast | 72% | 131.34 | 329 / 459 | 45% | 4.49 | 505 / 1118 |
bladder | 48% | 97.90 | 10 / 21 | 38% | 5.48 | 192 / 504 |
kidney | 61% | 72.55 | 54 / 89 | 1% | 0.04 | 7 / 901 |
skin | 57% | 162.20 | 1031 / 1809 | 0% | 0.10 | 1 / 472 |
esophagus | 7% | 6.28 | 107 / 1445 | 27% | 3.58 | 49 / 183 |
pancreas | 1% | 0.15 | 2 / 328 | 32% | 2.80 | 57 / 178 |
adipose | 26% | 18.19 | 308 / 1204 | 0% | 0 | 0 / 0 |
uterus | 2% | 1.15 | 4 / 170 | 14% | 1.16 | 66 / 459 |
lung | 2% | 0.59 | 9 / 578 | 10% | 1.61 | 114 / 1155 |
peripheral blood | 10% | 9.80 | 96 / 929 | 0% | 0 | 0 / 0 |
ovary | 1% | 0.24 | 1 / 180 | 7% | 0.33 | 31 / 430 |
heart | 7% | 2.29 | 56 / 861 | 0% | 0 | 0 / 0 |
spleen | 4% | 9.96 | 10 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 3% | 1.21 | 39 / 1335 | 0% | 0 | 0 / 0 |
thymus | 2% | 0.81 | 13 / 653 | 1% | 0.08 | 5 / 605 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.12 | 1 / 45 |
brain | 1% | 0.66 | 39 / 2642 | 0% | 0 | 0 / 705 |
adrenal gland | 1% | 0.41 | 3 / 258 | 0% | 0 | 0 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006071 | Biological process | glycerol metabolic process |
GO_0019432 | Biological process | triglyceride biosynthetic process |
GO_0006640 | Biological process | monoacylglycerol biosynthetic process |
GO_0050892 | Biological process | intestinal absorption |
GO_0006651 | Biological process | diacylglycerol biosynthetic process |
GO_1990578 | Cellular component | perinuclear endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0016407 | Molecular function | acetyltransferase activity |
GO_0003846 | Molecular function | 2-acylglycerol O-acyltransferase activity |
GO_0004144 | Molecular function | diacylglycerol O-acyltransferase activity |
Gene name | MOGAT2 |
Protein name | 2-acylglycerol O-acyltransferase 2 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (hMGAT2) (Diacylglycerol O-acyltransferase candidate 5) (hDC5) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 2) |
Synonyms | DC5 DGAT2L5 |
Description | FUNCTION: Involved in glycerolipid synthesis and lipid metabolism . Catalyzes the formation of diacylglycerol, the precursor of triacylglycerol, by transferring the acyl chain of a fatty acyl-CoA to a monoacylglycerol . Plays a central role in absorption of dietary fat in the small intestine by catalyzing the resynthesis of triacylglycerol in enterocytes (By similarity). Has a preference toward monoacylglycerols containing unsaturated fatty acids in an order of C18:3 > C18:2 > C18:1 > C18:0 at sn-2 . Able to use 1-monoalkylglycerol (1-MAkG, 1-O-alkylglycerol) as an acyl acceptor for the synthesis of monoalkyl-monoacylglycerol (MAMAG, 1-O-alkyl-3-acylglycerol or 1-O-alkyl-2-acylglycerol) and subsequently, with lower efficiency, may add another acyl chain producing monoalkyl-diacylglycerol (MADAG, 1-O-alkyl-2,3-diacylglycerol) . Possesses weak but significant activity with diacylglycerol as substrate, producing triacylglycerol (triacyl-sn-glycerol) . . |
Accessions | ENST00000525093.5 [Q3SYC2-3] Q3SYC2 ENST00000198801.10 [Q3SYC2-1] ENST00000526712.1 [Q3SYC2-2] |